Health · Medical Research · 1 hr ago

Alzheimer’s headset trial misses main goal but suggests benefit in mild cases

Alzheimer’s headset trial misses main goal but suggests benefit in mild cases

A 12-month trial tested Cognito Therapeutics’ light-and-sound headset in people with mild to moderate Alzheimer’s.

The device uses flickering light and sound to try to prompt brainwave responses that might help preserve brain function.

The trial’s main goal was to show slower cognitive decline, but the overall group did not decline more slowly than people using an inactive device.

Participants with moderate Alzheimer’s showed no benefit, while results suggested possible slower decline in mild cases, especially among those who used the headset nearly every day for about an hour.

The approach matters because it could offer a non-drug option for a disease whose medications can be expensive and carry safety risks.

Cognito’s chief executive said the company plans to seek Food and Drug Administration approval based on the results in people with mild Alzheimer’s.

1 source

Related

What people are saying

Christian HowellCognito Therapeutics chief executive
The signal we found in the mild population is really incredible
via NYT
the lack of treatment effect
via NYT
there is a very clear path for us to the F.D.A.
via NYT